The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
PTEN Mutation Spectrum and Genotype-Phenotype Correlations in Bannayan-Riley-Ruvalcaba Syndrome Suggest a Single Entity With Cowden Syndrome
Abstract
Germline mutations in the tumour suppressor gene PTEN have been implicated in two hamartoma syndromes that exhibit some clinical overlap, Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRR). PTEN maps to 10q23 and encodes a dual specificity phosphatase, a substrate of which is phosphatidylinositol 3,4,5-triphosphate, a phospholipid in the phosphatidylinositol 3-kinase pathway. CS is characterized by multiple hamartomas and an increased risk of benign and malignant disease of the breast, thyroid and central nervous system, whilst the presence of cancer has not been formally documented in BRR. The partial clinical overlap in these two syndromes is exemplified by the hallmark features of BRR: macrocephaly and multiple lipomas, the latter of which occur in a minority of individuals with CS. Additional features observed in BRR, which may also occur in a minority of CS patients, include Hashimoto's thyroiditis, vascular malformations and mental retardation. Pigmented macules of the glans penis, delayed motor development and neonatal or infant onset are noted only in BRR. In this study, constitutive DNA samples from 43 BRR individuals comprising 16 sporadic and 27 familial cases, 11 of which were families with both CS and BRR, were screened for PTEN mutations. Mutations were identified in 26 of 43 (60%) BRR cases. Genotype-phenotype analyses within the BRR group suggested a number of correlations, including the association of PTEN mutation and cancer or breast fibroadenoma in any given CS, BRR or BRR/CS overlap family ( P = 0.014), and, in particular, truncating mutations were associated with the presence of cancer and breast fibroadenoma in a given family ( P = 0.024). Additionally, the presence of lipomas was correlated with the presence of PTEN mutation in BRR patients ( P = 0.028). In contrast to a prior report, no significant difference in mutation status was found in familial versus sporadic cases of BRR ( P = 0.113). Comparisons between BRR and a previously studied group of 37 CS families suggested an increased likelihood of identifying a germline PTEN mutation in families with either CS alone or both CS and BRR when compared with BRR alone ( P = 0.002). Among CS, BRR and BRR/CS overlap families that are PTEN mutation positive, the mutation spectra appear similar. Thus, PTEN mutation-positive CS and BRR may be different presentations of a single syndrome and, hence, both should receive equal attention with respect to cancer surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hapeman, D. E. (1991) · Technometrics · doi:10.1080/00401706.1991.10484817 · Cited by 9,373
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Self-citationPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
The lipid phosphatase activity of PTEN is critical for its tumor supressor function
Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P., & Tonks, N. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13513 · Cited by 1,168
A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables
Mehta, C. R., & Patel, N. R. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477989 · Cited by 898
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
Eng, C. (1996) · JAMA · doi:10.1001/jama.1996.03540190047028 · Cited by 821
Self-citationSuzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 818
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775
Self-citationFrequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, G. S., & Sidransky, D. (1997) · PubMed · Cited by 700
Marsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653 · cited 9×
“In the present study, we have performed PTEN mutation analysis in 43 unrelated BRR cases, including a subset of families with both BRR and CS, and compared these data w those found in a previous study of 37 CS families (16).”
BackgroundMethodResultInfluentialSelf-citationThe Cowden syndrome: a clinical and genetic study in 21 patients
Starink, T. M., Veen, J. P. W. V. D., Arwert, F., Waal, L. P. D., Lange, G. G. D., Gille, J. J. P., & Eriksson, A. W. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00816.x · Cited by 550
A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables
Mehta, C. R., & Patel, N. R. (1983) · Journal of the American Statistical Association · doi:10.2307/2288652 · Cited by 538
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg, P., Straten, P. T., Birck, A., Ahrenkiel, V., Kirkin, A. F., & Zeuthen, J. (1997) · PubMed · Cited by 480
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
Nelen, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1383 · Cited by 464
Furnari, F. B., Huang, H., & Cavenee, W. K. (1998) · PubMed · Cited by 395
Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
Dahia, P. L. M., Marsh, D. J., Zheng, Z., Zedenius, J., Komminoth, P., Frisk, T., Wallin, G., Parsons, R. E., Longy, M., Larsson, C., et al. (1997) · PubMed · Cited by 327
Self-citationBannayan‐Riley‐Ruvalcaba syndrome
Gorlin, R. J., Cohen, M. M., Condon, L. M., & Burke, B. A. (1992) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320440309 · Cited by 315
Self-citationLi, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N. K., & Parsons, R. E. (1998) · PubMed · Cited by 306
Dahia, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.185 · Cited by 274
Self-citationMulligan, L. M., MARSH, D. J., ROBINSON, B. G., SCHUFFENECKER, I., ZEDENIUS, J., LIPS, C. J. M., GAGEL, R. F., TAKAI, S. ‐., NOLL, W. W., FINK, M., et al. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01208.x · Cited by 272
Self-citationSorsby, A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90662-7 · Cited by 262
Deletion of genes on chromosome 1 in endocrine neoplasia
Mathew, C. G. P., Smith, B. A., Thorpe, K., Wong, Z., Royle, N. J., Jeffreys, A. J., & Ponder, B. A. J. (1987) · Nature · doi:10.1038/328524a0 · Cited by 259
Lhermitte‐duclos disease and cowden disease: A single phakomatosis
Padberg, G. W., Schot, J. D. L., Vielvoye, G. J., Bots, G. T. A. M., & De Beer, F. C. (1991) · Annals of Neurology · doi:10.1002/ana.410290511 · Cited by 201
Hanssen, A. M., & Fryns, J. P. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.2.117 · Cited by 166
Germline PTEN mutations in Cowden syndrome-like families.
Marsh, D. J., Dahia, P. L., Caron, S., Kum, J. B., Frayling, I. M., Tomlinson, I. P., Hughes, K. S., Eeles, R. A., Hodgson, S. V., Murday, V. A., et al. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.11.881 · Cited by 162
Self-citationTsou, H. C., Teng, D. H. ‐., Ping, X. L., Brancolini, V., Davis, T., Hu, R., Xie, X. X., Gruener, A. C., Schrager, C. A., Christiano, A. M., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/301607 · Cited by 153
Self-citationArch, E. M., Goodman, B. K., Wesep, R. V., Liaw, D., Clarke, K. A., Parsons, R., Mckusick, V. A., & Geraghty, M. T. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970905)71:4<489::aid-ajmg24>3.3.co;2-i · Cited by 140
Self-citationCowden syndrome and lhermitte-duclos disease
Albrecht, S., Haber, R. M., Goodman, J. C., & Duvic, M. (1992) · Cancer · doi:10.1002/1097-0142(19920815)70:4<869::aid-cncr2820700424>3.0.co;2-e · Cited by 113
Cowden disease. Report of a family and review.
Longy, M., & Lacombe, D. (1996) · PubMed · Cited by 109
Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?
Eng, C., Murday, V. A., Seal, S., Mohammed, S. N., Hodgson, S. V., Chaudary, M. A., Fentiman, I. S., Ponder, B. A. J., & Eeles, R. A. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.6.458 · Cited by 108
Self-citationMutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype.
Longy, M., Coulon, V., Duboué, B., David, A., Larrègue, M., Eng, C., Amati‐Bonneau, P., Kraimps, J. L., Bottani, A., Lacombe, D., et al. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.11.886 · Cited by 107
Self-citationLipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome.
Ga, B. (1971) · PubMed · Cited by 104
Eng, C. (1997) · Journal of Genetic Counseling · doi:10.1023/a:1025664119494 · Cited by 103
Self-citationMacrocephaly with multiple lipomas and hemangiomas
Zonana, J., Rimoin, D. L., & Davis, D. C. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80397-6 · Cited by 101
Marsh, D. J., Dahia, P. L. M., Coulon, V., Zheng, Z., Dorion-Bonnet, F., Call, K. M., Little, R., Lin, A. Y., Eeles, R. A., Goldstein, A. M., et al. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199801)21:1<61::aid-gcc8>3.0.co;2-6 · Cited by 100
Self-citationVinchon, M., Blond, S., Lejeune, J. P., Krivosik, I., Fossati, P., Assaker, R., & Christiaens, J. L. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.6.699 · Cited by 87
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome.
Marsh, D. J., Roth, S., Lunetta, K. L., Hemminki, A., Dahia, P. L. M., Sistonen, P., Zheng, Z., Caron, S., van Orsouw, N. J., Bodmer, W. F., et al. (1997) · PubMed · Cited by 82
Self-citationMarsh, D. J., Zheng, Z., Zedenius, J., Kremer, H., Padberg, G. W. A. M., Larsson, C., Longy, M., & Eng, C. (1997) · PubMed · Cited by 69
Self-citationTsuchiya, K. D., Wiesner, G. L., Cassidy, S. B., Limwongse, C., Boyle, J. T., & Schwartz, S. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199802)21:2<113::aid-gcc6>3.0.co;2-3 · Cited by 67
Polymorphisms in PTEN in breast cancer families
Carroll, B. T., Couch, F. J., Rebbeck, T. R., & Weber, B. L. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.2.94 · Cited by 44
Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome.
Carethers, J. M., Furnari, F. B., Zigman, A., Lavine, J., Jones, M. C., Graham, G. E., Teebi, A. S., Huang, H., Ha, H. T., Chauhan, D. P., et al. (1998) · PubMed · Cited by 35
Cowden disease: gene marker studies and measurements of epidermal growth factor.
Carlson, H. E., Burns, T., Davenport, S. L. H., Luger, A. M., Spence, M. A., Sparkes, R. S., & Orth, D. N. (1986) · PubMed · Cited by 30
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109
A developmental and genetic classification for malformations of cortical development: update 2012
Barkovich, A. J., Guerrini, R., Kuzniecky, R. I., Jackson, G. D., & Dobyns, W. B. (2012) · Brain · doi:10.1093/brain/aws019 · Cited by 1,104
Automated inference of molecular mechanisms of disease from amino acid substitutions
Li, B., Krishnan, V. G., Mort, M. E., Xin, F., Kamati, K. K., Cooper, D. N., Mooney, S. D., & Radivojac, P. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp528 · Cited by 826
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3037 · Cited by 794
Metadata
- Authors
- Marsh, D. J., Kum, J. B., Lunetta, K. L., Bennett, M. J., Gorlin, R. J., Ahmed, S. F., Bodurtha, J., Crowe, C., Curtis, M. A., Dasouki, M., Dunn, T., Feit, H., Geraghty, M. T., Graham, J. M., Hodgson, S. V., Hunter, A., Korf, B. R., Manchester, D., Miesfeldt, S., Murday, V. A., Nathanson, K. L., Parisi, M., Pober, B., Romano, C., Tolmie, J. L., Trembath, R., Winter, R. M., Zackai, E. H., Zori, R. T., Weng, L.-P., Dahia, P. L. M., & Eng, C.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08-01
- Volume
- 8
- Issue
- 8
- Pages
- 1461-1472
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2122230708
- Cited by
- 612
- References
- 47
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.